tumor localization systems, tumor localization, elekta, radiation therapy

Elekta X-ray Volume Imaging (XVI)


September 13, 2013 – Integrated with Versa HD linear accelerator, Elekta has introduced new intra-fraction imaging capabilities within its X-ray Volume Imaging (XVI) system. During treatment, XVI now provides the tools to monitor and manage internal motion, supporting the clinician's efforts to increase therapeutic doses delivered to the tumor while reducing healthy tissue exposure.

"Regardless of patient immobilization, both the tumor and adjacent critical structures may move during treatment delivery. Historically, this has presented a significant challenge in delivering highly targeted treatments," says Dee Mathieson, Senior Vice President, Oncology Business Line Management.

"On a second by second basis, the precise location of the tumor and sensitive healthy structures can now be visualized, helping clinicians accurately deliver dose to the tumor while minimizing normal tissue exposure,” she adds

Elekta's XVI, which is also available on other Elekta radiotherapy delivery systems, includes 2-D, 3-D and 4-D intra-fraction imaging to support live imaging during sophisticated delivery techniques, such as Volumetric Modulated Arc Therapy (VMAT).

The new capabilities within XVI include seamless integration with Elekta's Mosaiq image-enabled oncology information system. XVI and Mosaiq work in harmony to deliver highly automated imaging workflow for improved control, efficiency, and performance. With image data available within the Oncology Information System, patient images, as well as setup and correction data, can be accessed as an integral part of the patient's electronic medical record.

The XVI 5.0 is pending FDA 510(k) clearance and not yet available for sale in the United States.


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now